The above chart shows Boston Scientific Corporation's revenue percentage share by segment (products and services).
In fiscal year 2023, Boston Scientific Corporation's revenue by segment is as follows:
- Cardiovascular generated $8.82 B in revenue, representing 61.93% of its total revenue.
- MedSurg generated $5.42 B in revenue, representing 38.07% of its total revenue.
The
biggest segment for Boston Scientific Corporation is the Cardiovascular, which represents 61.93% of its total revenue.
The
smallest segment for Boston Scientific Corporation is the MedSurg, which represents 38.07% of its total revenue.
The above chart shows Boston Scientific Corporation's revenue percentage share by segment (products and services).
In fiscal year 2024, Boston Scientific Corporation's revenue by segment is as follows:
- Cardiovascular generated $10.76 B in revenue, representing 64.22% of its total revenue.
- MedSurg generated $5.99 B in revenue, representing 35.78% of its total revenue.
The
biggest segment for Boston Scientific Corporation is the Cardiovascular, which represents 64.22% of its total revenue.
The
smallest segment for Boston Scientific Corporation is the MedSurg, which represents 35.78% of its total revenue.
The above chart shows Boston Scientific Corporation's revenue percentage share by segment (products and services).
In fiscal year 2025, Boston Scientific Corporation's revenue by segment is as follows:
- Cardiovascular generated $13.27 B in revenue, representing 66.02% of its total revenue.
- MedSurg generated $6.83 B in revenue, representing 33.98% of its total revenue.
The
biggest segment for Boston Scientific Corporation is the Cardiovascular, which represents 66.02% of its total revenue.
The
smallest segment for Boston Scientific Corporation is the MedSurg, which represents 33.98% of its total revenue.
Submit Feedback
